New Data in Simultaneous Pancreas-Kidney Transplantation Further Demonstrates the Value of Prospera dd-cfDNA Technology - Stockhouse
3/22/2022 12:00:00 AM3 years 1 month ago
by Stockhouse.com
by Stockhouse.com
New Data in Simultaneous Pancreas-Kidney Transplantation Further Demonstrates the Value of Prospera dd-cfDNA Technology
Biopsy-matched study assesses pancreas rejection in the context of a simultaneous kidney-pancreas transplant AUSTIN, Texas, March 22, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leade… [+5772 chars]
full article...